Eye Pitch Session
The Bench to Bedside (B2B) Organizing Committee seeks submissions of great ideas for new treatments, drugs or devices to be pitched to a panel of experts during the inaugural Bench to Bedside Meeting, being hosted virtually May 20 - 21. If you have an entrepreneurial mindset and little to no experience moving an idea forward through the pipeline, this session is for you.
If your pitch is selected, you will take part in a learning session with a panel of experts where you will present your 5- to 6-minute pitch for feedback.
At the end of the pitch session the expert panel will take part in a Q&A with the audience.
Additional pitches will be available to view during the Networking Reception from 1:15 - 2pm on May 21.
Pitch submission eligibility
Anyone with a great idea for a new treatment, drug or device in eye and vision research can submit a pitch. The organizing committee is especially interested in hearing about ideas and products in the early- to mid-development pipeline. Submitters do not need to be ARVO members, but are expected to register for the B2B Meeting and present the work if selected. Everyone can submit one idea for consideration.
Note: The B2B Meeting Committee expects that any ideas being presented are already protected by any appropriate patent applications.
Key dates for the 2021 B2B Meeting
Jan. 11 Pitch submission site opens
Feb. 12 Pitch submission deadline
March 5 Pitch acceptance and scheduling notification sent to submitter